대한간학회 APASL 2022 (DAY 2) : 2022-03-31
교육일자 : 2022-03-31
교육장소 : (온, 오프라인 병행) 오프라인 장소: 서울 코엑스  
교육주제 : (온-오프병행) APASL 2022 (DAY 2)
주최기관 : 대한간학회
담당자 : APASL 2022 준비사무국
연락처 : 02-707-0091  
이메일 : apasl2022@insession.co.kr      
교육종류 : 내과      
참석예상인원 : 1000명
희망평점 : 6점  
지역 : 서울특별시
교육시간 : 25 시간 50분  
세부수강료 : 800,000원      
비고 Category Early Bird Rate Regular Rate Onsite Rate December 31(Fri), 2021 February 20(Sun), 2022 Off-line Virtual Off-line Virtual Off-line VirtualAPASL Member USD 300 USD200 USD400 USD300 USD 500 USD 400Non APASL Member USD 500 USD 300 USD 600 USD 400 USD 700 USD 500Trainee/Resident/Nurse USD 200 USD 100 USD 300 USD 200 USD 400 USD 300Accompanying Person USD 150 - USD 200 - USD 300 -Industry Partner USD 600 USD 600 USD 700 USD 700 USD 800 USD 800 / *사전등록2022년 2월 20일(일)까지 [현장] 전문의 30만원, 전임의,전공의,간호사 15만원, 동반자 15만원, Industry Partner 70만원 [온라인] 전문의 25만원, 전임의,전공의,간호사 12만원, Industry Partner 70만원, *현장등록 [현장] 전문의 35만원, 전임의,전공의,간호사 18만원, 동반자 18만원, Industry Partner 80만원 [온라인] 전문의 30만원, 전임의/전공의/간호사 15만원, Industry Partner 80만원      

구분 월일 강의실 시간 교육제목  강사명(소속) 필수과목
교육시간 03-31 101+102, 1F 10:30~10:50 Expanding treatment indications for CHB  Young-Suk Lim(University of Ulsan College of Medicine) 
교육시간 03-31 101+102, 1F 10:50~11:10 Finite treatment of CHB with current antivirals: Is it possible?  Chun-Jen Liu(National Taiwan University College of Medicine and Hospital) 
교육시간 03-31 101+102, 1F 11:10~11:30 Current and promising surrogates to guide HBV therapy  Yasuhito Tanaka(Faculty of Life Sciences, Kumamoto University) 
교육시간 03-31 101+102, 1F 11:30~11:50 Future perspectives in HBV management  Henry LY Chan(Faculty of Medicine, The Chinese University of Hong Kong) 
토론 03-31 101+102, 1F 11:50~12:00 Discussion  () 
교육시간 03-31 101+102, 1F 13:30~13:50 Hepatocarcinogenesis in HBV-related HCC  Nobuyuki Enomoto(University of Yamanashi Faculty of Medicine) 
교육시간 03-31 101+102, 1F 13:50~14:10 HCC risk stratification in CHB patients treated with antivirals  Tai-Chung Tseng(National Taiwan University Hospital) 
교육시간 03-31 101+102, 1F 14:10~14:30 Prevention of HBV-related HCC through antiviral treatment  Jinlin Hou(Nanfang Hospital, Southern Medical University) 
교육시간 03-31 101+102, 1F 14:30~14:50 Prevention of HBV-related HCC beyond antiviral treatment  Jeong-Hoon Lee(Seoul National University College of Medicine) 
토론 03-31 101+102, 1F 14:50~15:00 Discussion  () 
교육시간 03-31 101+102, 1F 16:00~16:20 HBV cccDNA: A hurdle for a cure  Patrick Kennedy(Barts and The London School of Medicine & Dentistry) 
교육시간 03-31 101+102, 1F 16:20~16:40 CRISPR/Cas9: targeting cccDNA and integrated HBV  Kyun-Hwan Kim(Sungkyunkwan University School of Medicine) 
교육시간 03-31 101+102, 1F 16:40~17:00 Immunological cure of HBV infection  Qin Ning(Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology) 
교육시간 03-31 101+102, 1F 17:00~17:20 Current and emerging therapeutics for HBV cure  Man Fung Yuen(The University of Hong Kong) 
토론 03-31 101+102, 1F 17:20~17:30 Discussion  () 
교육시간 03-31 201+202, 2F 10:30~10:50 Pathogenic role of gut dysbiosis in ALD and NAFLD  GwangPyo Ko(Graduate School of Public Health, Seoul National University) 
교육시간 03-31 201+202, 2F 10:50~11:10 Gut microbiome-based personalized medicine in NAFLD  Rohit Loomba(University of California at San Diego) 
교육시간 03-31 201+202, 2F 11:10~11:30 Alterations of gut microbiome in cirrhosis and its complications  Jasmohan S. Bajaj(Virginia Commonwealth University School of Medicine) 
교육시간 03-31 201+202, 2F 11:30~11:50 Therapeutic role of FMT in chronic liver diseases  SM Shasthry(Institute of Liver and Biliary Sciences) 
토론 03-31 201+202, 2F 11:50~12:00 Discussion  () 
교육시간 03-31 201+202, 2F 13:30~13:50 Updates on pathogenesis of ALD  Kenichi Ikejima(Juntendo University School of Medicine) 
교육시간 03-31 201+202, 2F 13:50~14:10 Noninvasive diagnostic biomarkers in ALD  Suthat Liangpunsakul(Indiana University School of Medicine) 
교육시간 03-31 201+202, 2F 14:10~14:30 Upcoming pharmacological treatment in ALD  Gyongyi Szabo(Harvard Medical School) 
교육시간 03-31 201+202, 2F 14:30~14:50 Liver trasnplantation in ALD  Dong Jin Joo(Yonsei University College of Medicine) 
토론 03-31 201+202, 2F 14:50~15:00 Discussion  () 
교육시간 03-31 201+202, 2F 16:00~16:20 Viral hepatitis  Ji Hoon Kim(Korea University College of Medicine) 
교육시간 03-31 201+202, 2F 16:20~16:40 NAFLD and ALD  Rosmawati Mohamed(Faculty of Medicine, University of Malaya) 
교육시간 03-31 201+202, 2F 16:40~17:00 Cirrhosis  Cosmas Rinaldi Lesmana(Dr. Cipto Mangunkusumo National General Hospital) 
교육시간 03-31 201+202, 2F 17:00~17:20 Liver cancer  Kang Mo Kim(University of Ulsan College of Medicine) 
토론 03-31 201+202, 2F 17:20~17:30 Discussion  () 
교육시간 03-31 203, 2F 10:30~10:50 HCV elimination: Korean expriences  Do Young Kim(Yonsei University College of Medicine) 
교육시간 03-31 203, 2F 10:50~11:10 HCV elimination: Turkey experiences  A.Kadir Dokmeci(Ankara University School of Medicine) 
교육시간 03-31 203, 2F 11:10~11:30 Global strategies for HCV microelimination  Lai Wei(Tsinghua University School of Clinical Medicine) 
교육시간 03-31 203, 2F 11:30~11:50 APASL strategies for HCV elimination in Asia-Pacific Region  Saeed Sadiq Hamid(Aga Khan University and Hospital) 
토론 03-31 203, 2F 11:50~12:00 Discussion  () 
교육시간 03-31 203, 2F 13:30~13:50 Impact of DAA therapy in advanced/decompensated cirrhosis  Alexander Thompson(St. Vincent’s Hospital Melbourne) 
교육시간 03-31 203, 2F 13:50~14:10 When is optimal time for DAA therapy in patients with HCC?  Ming-Lung Yu(Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung) 
교육시간 03-31 203, 2F 14:10~14:30 Does DAA therapy increase survival in patients with HCV-related HCC?  Yock Young Dan(National Univeristy Hospital) 
교육시간 03-31 203, 2F 14:30~14:50 Mangement of HCV patients after achieving SVR by DAA therapy  Jung Hyun Kwon(College of Medicine, The Catholic University of Korea) 
토론 03-31 203, 2F 14:50~15:00 Discussion  () 
교육시간 03-31 205A, 2F 08:00~08:20 Scientific strategy to cure hepatitis B  Peter Revill(Royal Melbourne Hospital) 
교육시간 03-31 205A, 2F 08:20~08:40 Hot topics in basic science for HBV elimination  Pei-Jer Chen(National Taiwan University Hospital) 
토론 03-31 205A, 2F 08:40~09:00 Discussion  () 
교육시간 03-31 205B, 2F 08:00~08:20 HBeAg-Positive “Gray Zone” Phase  Hyung Joon Yim(Korea University College of Medicine) 
교육시간 03-31 205B, 2F 08:20~08:40 HBeAg-Negative “Gray Zone” Phase  Yi-Hsiang Huang(Taipei Veterans General Hospital) 
토론 03-31 205B, 2F 08:40~09:00 Discussion  () 
교육시간 03-31 209A, 2F 08:00~08:20 Managment of viremic HCV-related decompensated cirrhosis  Chia-Yen Dai(Kaohsiung Medical University Hospital) 
교육시간 03-31 209A, 2F 08:20~08:40 Management of viremic HCV-related HCC  Soo Young Park(Kyungpook National University College of Medicine) 
토론 03-31 209A, 2F 08:40~09:00 Discussion  () 
교육시간 03-31 209A, 2F 08:00~08:20 Lille score-based, steroid non-responder with alcoholic hepatitis: G-CSF  Young Kul Jung(Korea University College of Medicine) 
교육시간 03-31 209A, 2F 08:20~08:40 Lille score-based, steroid non-responder with alcoholic hepatitis: FMT  Ki Tae Suk(Hallym University College of Medicine) 
토론 03-31 209A, 2F 08:40~09:00 Discussion  () 
교육시간 03-31 209AB, 2F 10:30~10:50 Malnutrition and fraility in cirrhosis  Puneeta Tandon(University of Alberta) 
교육시간 03-31 209AB, 2F 10:50~11:10 Sleep disturbance and depression in cirrhosis  Jeong-Ju Yoo(Soonchunhyang University College of Medicine) 
교육시간 03-31 209AB, 2F 11:10~11:30 Optimal management of hepatogenous diabetes  Ming Chih Hou(Taipei Veterans General Hospital) 
교육시간 03-31 209AB, 2F 11:30~11:50 Hormonal and erectile dysfunction in cirrhosis  Won Hyeok Choe(Konkuk University School of Medicine) 
토론 03-31 209AB, 2F 11:50~12:00 Discussion  () 
교육시간 03-31 209AB, 2F 13:30~13:50 Updates on epidemiology of PBC and autoimmune liver diseases  Kyung-Ah Kim(Inje University College of Medicine) 
교육시간 03-31 209AB, 2F 13:50~14:10 Advances in diagnosis of PBC and autoimmune liver diseases  Gideon M Hirschfield(University of Toronto) 
교육시간 03-31 209AB, 2F 14:10~14:30 Current and emerging treatments for PBC and autoimmune liver diseases  Ja Kyung Kim(Yonsei University College of Medicine) 
교육시간 03-31 209AB, 2F 14:30~14:50 Management of PBC and autoimmune diseases refractory to immunosuppressive regimens  Atsushi Tanaka(Teikyo University School of Medicine) 
토론 03-31 209AB, 2F 14:50~15:00 Discussion  () 
교육시간 03-31 209AB, 2F 16:00~16:20 Definition of ALD spectrum nomenclatures and trial endpoints  Eileen L. Yoon(Hanyang University College of Medicine) 
교육시간 03-31 209AB, 2F 16:20~16:40 Controversies in clinical trials for alcoholic hepatitis  Suthat Liangpunsakul(Indiana University School of Medicine) 
교육시간 03-31 209AB, 2F 16:40~17:00 Past pivotal clinical trials in alcoholic hepatitis treatment  Jae-Youn Cheong(Ajou University School of Medicine) 
교육시간 03-31 209AB, 2F 17:00~17:20 NIAAA consortium for alcoholic hepatitis clinical trials  Puneet Puri(Virginia Commonwealth University and McGuire VA Medical Center) 
토론 03-31 209AB, 2F 17:20~17:30 Discussion  () 
교육시간 03-31 Auditorium, 3F 09:00~09:15 Single-cell RNA sequencing in HCC  Zemin Zhang(School of Life Sciences, Peking University) 
교육시간 03-31 Auditorium, 3F 09:15~09:30 Spectrum of Wnt/β-catenin oncogenic "drivers" in serially occurring HCC nodules; Needs of tumorized therapy  Masao Omata(Yamanashi Central and Kita Hospitals, The University of Tokyo) 
교육시간 03-31 Auditorium, 3F 09:30~09:45 Sensitive and accurate viral integration detection in HBV-associated hepatocellular carcinoma  Xueying Lyu(Department of Pathology, The University of Hong Kong) 
교육시간 03-31 Auditorium, 3F 09:45~10:00 Validation of a new HBV cure strategy in HBV infected uPA/SCID chimeric mice  Yong-Yuan Zhang(HBVtech) 
교육시간 03-31 Auditorium, 3F 10:30~10:50 Okuda-Omata Distinguished Award  TBD() 
교육시간 03-31 Auditorium, 3F 10:50~11:10 Powell-Sarin Lifetime Achievement Award  TBD() 
교육시간 03-31 Auditorium, 3F 11:10~11:30 Sollano-Lesmana Great Mentor Award  TBD() 
교육시간 03-31 Auditorium, 3F 11:40~12:00 Rising Star Award Session - Presenter 1  TBD() 
교육시간 03-31 Auditorium, 3F 13:30~14:00 From NAFLD to NASH and HCC: Current concepts and future perspectives  Jin Mo Yang(College of Medicine, The Catholic University of Korea) 
교육시간 03-31 Auditorium, 3F 14:00~14:30 Acute kidney injury and hepatorenal syndrome  Paolo Angeli(University-Teaching Hospital of Padova) 
교육시간 03-31 Auditorium, 3F 14:30~15:00 Regenerative medicine in decompensated cirrhosis  Soon Koo Baik(Yonsei University Wonju College of Medicine) 
교육시간 03-31 Auditorium, 3F 16:00~16:20 Difference in characteristics of NALFD between Eastern and Western countries  Ming-Hua Zheng(The First Affiliated Hospital of Wenzhou Medical University) 
교육시간 03-31 Auditorium, 3F 16:20~16:40 Recent updates of clinical trials on NASH  Mary E. Rinella(Northwestern University Feinberg School of Medicine) 
교육시간 03-31 Auditorium, 3F 16:40~17:00 NAFLD-Associated HCC: Pathogenesis, clinical characteristics, and outcome  Dae Won Jun(Hanyang University College of Medicine) 
교육시간 03-31 Auditorium, 3F 17:00~17:20 Liver transplantation with steatotic donor livers – the science behind their outcomes  Laurie D. De Leve(Keck School of Medicine, USC) 
토론 03-31 Auditorium, 3F 17:20~17:30 Discussion  ()